DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Allegra-D 24 Hour (Fexofenadine Hydrochloride / Pseudoephedrine Hydrochloride) - Summary



ALLEGRA-D® 24 HOUR (fexofenadine hydrochloride and pseudoephedrine hydrochloride) Extended-Release Tablets for oral administration contain 180 mg fexofenadine hydrochloride for immediate release and 240 mg pseudoephedrine hydrochloride for extended release.

ALLEGRA-D 24 HOUR (FEXOFENADINE/PSEUDOEPHEDRINE) is indicated for the following:

See all Allegra-D 24 Hour indications & dosage >>


Media Articles Related to Allegra-D 24 Hour (Fexofenadine / Pseudoephedrine)

Hay Fever (Allergic Rhinitis)
Source: MedicineNet Allergic Cascade Specialty [2016.10.07]
Title: Hay Fever (Allergic Rhinitis)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 10/7/2016 12:00:00 AM

more news >>

Clinical Trials Related to Allegra-D 24 Hour (Fexofenadine / Pseudoephedrine)

Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions [Completed]

Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed Conditions [Completed]

A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge [Completed]
An H3 receptor antagonist should reduce the congestion associated with allergic rhinitis. A nasal allergen challenge will be given to patients to induce rhinitis symptoms and acoustic rhinometry will be used to measure the congestion.

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis [Completed]
PF-03654764 should reduce the symptoms of allergic rhinitis. In this study patients will be exposed to pollen and their symptoms observed.

more trials >>

Page last updated: 2016-10-07

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017